Mosaic ImmunoEngineering, Inc.
CPMV
$0.65
-$0.1057-13.99%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 133.90K | 146.80K | 213.60K | 201.50K | 225.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 150.20K | 186.40K | 274.30K | 268.80K | 275.60K |
| Operating Income | -150.20K | -186.40K | -274.30K | -268.80K | -275.60K |
| Income Before Tax | -150.60K | -186.70K | -293.70K | -288.50K | -295.60K |
| Income Tax Expenses | 2.40K | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -153.00K | -186.70K | -293.70K | -288.50K | -295.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -153.00K | -186.70K | -293.70K | -288.50K | -295.60K |
| EBIT | -150.20K | -186.40K | -274.30K | -268.80K | -275.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.03 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.03 | -0.02 | -0.03 |
| EPS Diluted | -0.02 | -0.03 | -0.04 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.03 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 7.24M | 7.24M | 7.24M | 7.24M | 7.24M |
| Average Diluted Shares Outstanding | 7.24M | 7.24M | 7.24M | 7.24M | 7.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |